Skip to content

C-reactive protein-triglyceride-glucose index and incident mild cognitive impairment among patients with cardiovascular-kidney-metabolic syndrome: a dual-cohort prediction and double machine learning analysis.

Sep 2026 · Journal of Endocrinological Investigation · 0 citations · 40 references
Medicine

TL;DR

CTI reliably predicts incident MCI in patients with CKM syndrome, the gradient boosting framework provides a robust risk stratification, and higher cognitive reserve may attenuate CTI-associated cognitive risk.

View source

Similar papers

Review Oct 2026

C-reactive protein–triglyceride–glucose index and advanced cardiovascular-kidney-metabolic syndrome in middle-aged and older adults: A cross-population study

Cardiovascular–kidney–metabolic (CKM) syndrome integrates metabolic risk, kidney dysfunction and cardiovascular disease. The C-reactive protein–triglyceride–glucose index (CTI) combines inflammatory, lipid and glycaemic measures, but its association with advanced CKM across populations remains unclear. Cross...

Ming Wu, Q. Zhou, Wen-Wu Zhou et al. · 0 citations
Review Open access Sep 2026

Association and predictive value of the C-reactive protein-triglyceride-glucose index in chronic kidney disease

Recent evidence has suggested a positive association between the C-reactive protein-triglyceride-glucose index (CTI) and chronic kidney disease (CKD), but its generalizability and prognostic utility remain to be fully established. In this study, we examined the CTI and CKD association in a nationally representative U...

Yu-Tong Lin, Jie Tian, Y. Zeng et al. · 1 citation
Open access Sep 2026

Antecedent, landmark, and two-visit cumulative triglyceride-glucose index and non-traditional lipid measures in relation to incident cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome (CKM) stages 0–3: a nationwide prospective cohort study

Higher two-visit cumulative TyG-nTLP burden was associated with incident CVD after accounting for competing death, and incremental discrimination was small, and shared laboratory components limit claims of biological independence or synergy.

Ao Lu, Qian Xu · 0 citations
Review Open access Sep 2026

C-Reactive Protein-Triglyceride-Glucose Index, Inflammatory-Metabolic Burden, and Prevalent Stroke in U.S. Adults: NHANES 1999-2010

Background The C-reactive protein-triglyceride-glucose index (CTI) integrates inflammatory and metabolic markers, but recent studies have already linked CTI to stroke and cardiovascular outcomes. Whether CTI provides information beyond established risk factors in the U.S. general population remains uncertain. Methods W...

Q. Deng, Z. Yin · 0 citations
Open access Oct 2026

Triglyceride–glucose muscle-loss index and all-cause and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome stages 0–3: NHANES findings with validation in CHARLS

A composite triglyceride–glucose–muscle loss index (TyG-MLI), integrating insulin resistance (TyG) and a muscle-related metabolic reserve signal (cystatin C/creatinine ratio), may improve risk stratification in cardiometabolic–kidney–metabolic (CKM) stages 0–3, but its prognostic value is unclear. To exami...

Z. Chen, Z. Chang, S. Zhang et al. · 0 citations
Review Open access Oct 2026

A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study

CKMAI is a valid, CKM‑specific index that outperforms universal biological age measures in predicting mortality and high‑risk CKM status and consistently outperformed PhenoAge, KDM, and the cardiometabolic index across all outcomes.

Zheng-Yang Zhu, Ke-Jun Ren, Dong Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.